Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01886690
Other study ID # 11002X-002
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date August 20, 2013
Est. completion date August 18, 2014

Study information

Verified date April 2019
Source Allergan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will compare the safety and efficacy of a new eye drop formulation with REFRESH PLUS® in participants following LASIK surgery.


Recruitment information / eligibility

Status Completed
Enrollment 148
Est. completion date August 18, 2014
Est. primary completion date August 18, 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

-Patients scheduled for LASIK surgery in both eyes.

Exclusion Criteria:

- Any systemic medication use within 3 months of screening (including over the counter, herbal, prescription, or nutritional supplement) which may affect dry eye or vision

- Use of topical eye medication other than prescribed for use in pre- or post-operative care

- Use of RESTASISĀ® or other topical ophthalmic cyclosporine product within 6 months prior to Screening

- Eye infection, inflammation, or allergy

- Soft contact lenses in the previous 7 days or rigid contact lenses in the previous 30 days prior to LASIK surgery.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
carboxymethylcellulose sodium based new eye drop formulation
1 to 2 drops of carboxymethylcellulose sodium based New Eye Drop Formulation in each eye as per protocol for 90 days.
carboxymethylcellulose sodium based eye drops
1 to 2 drops carboxymethylcellulose sodium based (REFRESH PLUS®) eye drops in each eye as per protocol for 90 days.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Allergan

Countries where clinical trial is conducted

Australia,  Canada, 

References & Publications (1)

Wallerstein A, Jackson WB, Chambers J, Moezzi AM, Lin H, Simmons PA. Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose. Clin Ophthalmol. 2018 May 7;12:839-848. doi: 10.2147/OPTH.S163744. eCollection 2018. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Ocular Surface Disease Index© (OSDI) Score Using a 5-Point Scale The OSDIĀ© is a 12-question survey for patients to document their dry eye disease symptoms. Each question is rated on a 5-point scale (0=none of the time and 4 = all of the time). The scores are totaled over the 12 questions and normalized/converted to a score of 0-100 (0=no disability and 100=complete disability). Day 90
Secondary Change From Baseline in Corneal Staining in the Worse Eye The cornea is the transparent front part of the eye which covers the iris and pupil. Corneal staining in the worse eye following administration of fluorescein dye in the eye is graded using a 6-point scale (0=no staining, 5=severe staining) over 5 areas of the clear central part of the eye for a minimum score of 0 and maximum score of 25. The higher the grade score, the worse the dry eye condition. A negative change from baseline represents a decrease in corneal staining (improvement) and a positive change from baseline represents an increase in corneal staining (worsening). Baseline, Day 90
Secondary Change From Baseline in Tear Break-up Time (TBUT) in the Worse Eye TBUT is the time required for dry spots to appear on the surface of the eye after blinking in the worse eye. The longer it takes, the more stable the tear film. A short TBUT is a sign of poor tear film. A positive number change from baseline indicates an increase in TBUT (improvement) and a negative number change from baseline indicates a decrease in TBUT (worsening). Baseline, Day 90
Secondary Change From Baseline in the Schirmer Test in the Worse Eye The Schirmer's Test measures the rate of the secretion of tears produced by the eye over 5 minutes in the worse eye. The results indicate the presence of dry eye (Normal = greater than or equal to 10 millimeters (mm) of tears, Dry Eye = less than 10 mm of tears). The smaller the number, the more severe the dry eye. A positive number change from baseline indicates an increase in tears (improvement) and a negative number change from baseline indicates a decrease in tears (worsening). Baseline, Day 90
Secondary Change From Baseline in Uncorrected Visual Acuity in the Worse Eye Uncorrected visual acuity in the worse eye is measured using an eye chart and is reported as the number of letters read correctly (ranging from 0 to 100 letters) without corrective lenses. The lower the number of letters read correctly on the eye chart, the worse the vision (or visual acuity). A positive number change from baseline in the number of letters read correctly indicates an improvement and a negative number change from baseline indicates a worsening. Baseline, Day 90